PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1836300
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1836300
Veterinary Stereotactic Radiosurgery System Market size was valued at US$ 3,281.83 Million in 2024, expanding at a CAGR of 10.50% from 2025 to 2032.
Veterinary stereotactic radiosurgery (SRS) uses finely focused radiation beams to treat cancers and other health issues in the neck, lungs, brain, liver, spine, and other areas of the body. The procedure involves no incisions. Instead, stereotactic radiosurgery uses 3D imaging to focus high radiation doses on the affected area while minimizing damage to healthy tissue nearby.
Veterinary Stereotactic Radiosurgery System Market- Market Dynamics
PET Population Surge Drives Growth in the Veterinary Stereotactic Radiosurgery System Market.
The increasing PET population is expected to drive the future growth of the veterinary stereotactic radiosurgery system market. A pet is an animal kept in the home for enjoyment and company. The veterinary stereotactic radiosurgery system helps to treat tumors in pets with different head sizes and shapes. For instance, according to the People's Dispensary Sick Animals Wellness (PAW) Report, the UK's largest yearly examination of PET wellness, in 2023, 53% of UK adults will own a pet, with 29% owning a dog, 24% owning a cat, and 2% owning a rabbit. 67% of veterinary practitioners report an increase in the PET population over the last two years, with 71% citing more pets in their clinic and 54% citing more new pets in their community. As a result, the growing PET population is driving the veterinary stereotactic radiosurgery system market.
Veterinary Stereotactic Radiosurgery System Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 10.50% over the forecast period (2025-2032)
According to product segmentation, LINAC was expected to reach its largest market share in 2025.
Based on End Use segmentation, Hospitals and clinics are anticipated to grow at the fastest CAGR.
North America was the top revenue-generating region in 2025.
The Global Veterinary Stereotactic Radiosurgery System Market is segmented on the basis of Product, End Use, and Region.
The market is divided into four categories based on Product: Gamma Knife, LINAC, CyberKnife, and Proton Beam Radiation Therapy (PBRT)/ Flash-RT. In 2025, the LINAC (linear accelerator) system segment will dominate the market. Linear accelerator adoption is being driven by increased pet ownership, rising healthcare spending, and advances in veterinary oncology, which are making these technologies more effective and precise. Growing pet owner awareness, as well as the expansion of specialized veterinary centers, all contribute to the demand for advanced treatment options like linear accelerators. For instance, in October 2023, Washington State University installed a linear accelerator at its veterinary teaching hospital to provide advanced radiation therapy to animals with cancers such as mast cell tumors and soft tissue sarcomas.
The market is divided into two categories based on End Use: Hospitals & Clinics, and Academic & Research Institutions. Hospitals and clinics are expected to grow at the fastest CAGR. This expansion can be attributed to factors such as improved healthcare infrastructure and facilities, more skilled professionals, established patient trust, the presence of large networks, technological advancements, and the availability of nearby patients. Furthermore, clinics' low-cost treatments contribute to the market's growth.
Veterinary Stereotactic Radiosurgery System Market- Geographical Insights
In 2025, North America will dominate the market for veterinary stereotactic radiosurgery systems. This dominance can be attributed to factors such as the growing number of pets in the region, the presence of major players, an increase in research and studies for pet treatment, and increased heavy investments by the government and private players in pet improvement, all of which have contributed to market growth.
The Asia Pacific veterinary stereotactic radiosurgery system market is projected to grow at the fastest CAGR. Factors such as the presence of countries such as China, India, Japan, and others, rising pet adoption rates, and pet owners' awareness of their pets' health and wellness have all had a significant impact on the market's growth. Furthermore, rising disposable incomes have fueled regional market growth.
The veterinary stereotactic radiosurgery system market is moderately competitive, with growing demand for advanced, non-invasive cancer treatments in companion animals. Leading companies like Elekta, Varian Medical Systems, Inc., ALCEN, Xstrahl, and Accuracy Incorporated offer cutting-edge technologies for veterinary use, including CyberKnife and LINAC-based systems. These companies compete by developing innovative precision radiation delivery, treatment planning software, and integrated imaging systems. Startups and specialty veterinary clinics are also entering the market with tailored pet oncology solutions, adding to the competitive dynamic. North America leads in adoption due to well-established veterinary infrastructure and high pet healthcare spending, whereas Europe and Asia-Pacific are seeing rising growth due to increased awareness and investment in veterinary oncology services.
In September 2024, LSU Vet Med has acquired a Varian Trilogy linear accelerator, which provides advanced stereotactic radiotherapy and IMRT with RapidArc technology. This improves cancer treatment precision, reduces side effects, and shortens patient sedation time, demonstrating the growing use of stereotactic radiosurgery systems in veterinary oncology.